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Abstract
Polychlorinated biphenyls (PCBs) are ubiquitous pollutants which accumulate in the food
chain. Recently, several molecular mechanisms by which non-dioxin-like (NDL) PCBs
mediate neurodevelopmental and neurobehavioral toxicity have been elucidated. However,
although the G-protein coupled receptor (GPCR) is a significant target for neurobehavioral
disturbance, our understanding of the effects of PCBs on GPCR signaling remains unclear.
In this study, we investigated the effects of NDL-PCBs on GPCR-mediated Ca2+ signaling
in PC12 cells. We found that ortho-substituted 2,2’,6-trichlorinated biphenyl (PCB19)
caused a rapid decline in the Ca2+ signaling of bradykinin, a typical Gq- and phospholipase
Cβ-coupled GPCR, without any effect on its inositol 1,4,5-trisphosphate production. PCB19
reduced thapsigargin-induced sustained cytosolic Ca2+ levels, suggesting that PCB19
inhibits SOCE. The abilities of other NDL-PCBs to inhibit store-operated Ca2+ entry (SOCE)
were also examined and found to be of similar potencies to that of PCB19. PCB19 also
showed a manner equivalent to that of known SOCE inhibitors. PCB19-mediated SOCE
inhibition was confirmed by demonstrating the ability of PCB19 to inhibit the SOCE current
and thapsigargin-induced Mn2+ influx. These results imply that one of the molecular mecha-
nism by which NDL-PCBs cause neurobehavioral disturbances involves NDL-PCB-medi-
ated inhibition of SOCE, thereby interfering with GPCR-mediated Ca2+ signaling.
Introduction
Polychlorinated biphenyls (PCBs) are some of the most ubiquitous environmental contami-
nants presently originating from industry. Their characteristics (e.g. inflammability and electric
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conductivity) have brought them to a range of applications such as coolants, flame retardants,
and hydraulic fluids [1, 2]. Furthermore, the low water solubility and degradability of PCBs
enable them to be readily deposited in human, fish, bird and plant tissues, thereby accumulat-
ing at several stages of the food chain [3]. This accumulation is problematic, because PCBs are
toxic to nearly every tissue of humans and animals, including those of the endocrine, immune,
metabolic, reproductive, and nervous systems [2]. Moreover, PCBs have been reported to be
highly neurotoxic, with exposure to PCBs resulting in neurodevelopmental impairment and
neurobehavioral disturbances [4–6]. Since PCBs tend to accumulate in blood and are secreted
via breast milk [7–8], wide and intensive interest has also been given to the effects of PCBs on
motor activity, learning, and memory attention in infants and children [9–12].
PCBs have been classified into dioxin-like (DL) and non-dioxin-like (NDL) groups [13].
DL-PCBs with chlorine atoms at themeta or para position of the phenyl ring show coplanar or
dihedral molecular shape. On the other hand, NDL-PCBs are molecules containing chlorine
substitutions at the ortho position of the phenyl ring and exhibiting a toxicological profile dis-
tinct from that of DL-PCBs [13]. NDL-PCBs have been shown to act via a pathway that is inde-
pendent from the activation of the arylhydrocarbon receptor (AhR), a common mediator for
the actions of DL-PCBs and 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD). The most striking
attribute of NDL-PCBs is their ability to modulate intracellular Ca2+ signaling. NDL-PCBs
induce inositol phosphate accumulation [14], disrupt microsomal Ca2+ transport [15], change
phospholipase A2 activity [16], and increase Ca
2+ release from ryanodine receptors-sensitive
intracellular Ca2+ pools [17–19]. NDL-PCBs-triggered sustained increase in cytosolic Ca2+
level thereby perturb Ca2+-triggered physiological responses and subsequent gene expression
[20], and induce mitochondrial dysfunction [21].
However NDL-PCBs show more broad spectrum of neurotoxicity. NDL-PCBs increase a
risk of autism spectrum disorder and/or attention deficit hyperactive disorder, which is hard to
be simply explained with sustained Ca2+ increase and subsequent neuronal cell death [6].
Nonetheless, no information has been reported to date regarding potential crosstalk between
NDL-PCBs and other neurotransmitters, especially with respect to G-protein coupled receptor
(GPCR)-mediated Ca2+ signaling. Changes in neurotransmitter-mediated signaling are of great
consequence, since they potentially affect neuronal cell-to-cell communication and can result
in drastic neurophysiological perturbations. Because of their roles in hormonal and neuro-
transmitter function, GPCRs are especially critical targets for neurotoxic agents. Here, we
report that NDL-PCBs block GPCR-mediated Ca2+ signaling pathways by inhibiting store-
operated Ca2+ entry (SOCE). SOCE, also referred to as capacitative Ca2+ entry, comprises one
of the key mechanisms by which GPCRs and phospholipase C (PLC) mediate increases in cyto-
solic Ca2+ levels. The aim of this study was to elucidate the cellular mechanisms by which
NDL-PCBs perturb neuronal GPCR signaling.
Results
PCB19 inhibits bradykinin-induced Ca2+ signaling without any effect on
phospholipase C activity
PC12 cells have classically been used to study the neurotoxicological properties of PCBs (Fig
1), as well as to characterize G-protein coupled receptors, for decades [22–24]. We examined
the effect of PCB19 on GPCR-mediated [Ca2+]i increases in PC12 cells, and confirmed the pre-
vious finding that 50 μM PCB19 induces a sustained increase in intracellular Ca2+ levels (Fig
2A). Interestingly, we also found that PCB19 partially inhibited bradykinin-induced [Ca2+]i
increases; furthermore, this inhibition was markedly enhanced in the “Ca2+-decreasing state”
(P = 0.0038, t(11) = 3.653) (Fig 2A). These data suggest that PCB19 eventually weakens
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bradykinin receptor-mediated Ca2+ signaling. Moreover, neither PCB36 (AhR-activating
DL-PCB) nor TCDD (AhR-activating dioxin) stimulated any Ca2+ increase by themselves,
and both were also less effective than PCB19 to inhibit subsequent bradykinin-induced Ca2+
increase (Fig 2B and 2C).
Fig 1. Structures of PCBs. PCB4 (2,2’-dichlorinated biphenyl), PCB19 (2,2’,6-trichlorinated biphenyl), PCB50 (2,2’,4,6-tetrachlorinated biphenyl), and
PCB100 (2,2’,4,4’,6-pentachlorinated biphenyl) have chlorine atoms at the ortho position of the phenyl ring, whereas PCB36 (3,3’,5-trichlorinated biphenyl)
contains chlorine substitution at themeta position of the phenyl ring.
doi:10.1371/journal.pone.0150921.g001
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Fig 2. PCB19 inhibits bradykinin-induced increases of [Ca2+]i in PC12 cells. (right) Fura-2-loaded PC12 cells were challenged with 50 μMPCB19 (A),
50 μMPCB36 (B), or 50 nM TCDD (C) and subsequently treated with 300 nM bradykinin. Responses to bradykinin alone, without PCB pretreatment, are also
depicted (dotted traces). BK, bradykinin. (left) Peak changes in bradykinin-induced [Ca2+]i increase were quantitatively analyzed. Number of experiments are
depicted in bar graph and each point represents mean ± SEM. **P < 0.01.
doi:10.1371/journal.pone.0150921.g002
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Activation of GPCRs and PLC results in elevated [Ca2+]i through a mechanism involving
inositol 1,4,5-trisphosphate (InsP3)-dependent Ca
2+ release from internal stores and subse-
quent SOCE from the extracellular space [25]. Thus, GPCR-mediated Ca2+ signaling is modu-
lated at multiple levels, including the receptor itself, G-proteins, PLC, the InsP3 receptor, and
the Ca2+ pool, as well as SOCE. To test whether PCB19 affects GPCR signaling, such as recep-
tor activation and/or PLC activation, we examined whether NDL-PCBs affected InsP3 produc-
tion. We found that NDL-PCBs, including PCB4 and PCB19, did not increase cytosolic InsP3
levels, whereas treatment with bradykinin successfully generated InsP3 (Fig 3A). Furthermore,
NDL-PCBs did not inhibit either bradykinin- or UTP- (another Gq-coupled P2Y2 receptor
agonist) induced InsP3 production (Fig 3B). Thus, we conclude that NDL-PCB-mediated inhi-
bition of SOCE does not involve regulation of PLC activity.
PCB19-induced Ca2+ influxes are relatively smaller than Ca2+ release
Since the inhibitory effect of PCB19 on bradykinin-induced Ca2+ increase was more prominent
in the decay phase than the initial phase, we focused subsequent studies on intracellular Ca2+
release and SOCE rather than on the earlier steps of GPCR and PLC activation. Similar to
PCB19 (Fig 4A), thapsigargin (an inhibitor of the sarco/endoplasmic Ca2+ ATPase) depleted
intracellular Ca2+ pools and induced subsequent SOCE (Fig 4B). However, the amplitude of
PCB19-induced Ca2+ influx induced by reintroduced CaCl2 in the Ca
2+-free condition was
much smaller than that induced by thapsigargin-induced Ca2+ influx, even though the ampli-
tude of PCB19-induced Ca2+ release in the Ca2+-free condition was similar to that induced by
thapsigargin. This same trend was observed upon treatment with ionomycin, which is a Ca2+
ionophore and induces both Ca2+ release from intracellular stores, as well as Ca2+ influx from
the extracellular space. Even though 300 nM ionomycin induced an amount of Ca2+ release
similar to that induced by PCB19, the ionomycin-induced Ca2+ increase in the presence of
extracellular Ca2+ was much larger than that induced by PCB19, most likely because less Ca2+
influx is triggered by PCB19 (Fig 4D). Also we found that thapsigargin or ionomycin evoked
rapid and transient Ca2+ release, which returned to baseline within 1–2 min. By contrast,
PCB19 induced a gradual and prolonged Ca2+ release, which did not return to basal level
within the recording period. Considering the comparatively small Ca2+ influx triggered by
PCB19, we hypothesized that PCB19 inhibits SOCE. In extracellular Ca2+ free condition, pre-
treatment with PCB19 did not affect ionomycin-induced Ca2+ release but blocked subsequent
ionomycin-induced Ca2+ influx (P< 0.0001, t(9) = 9.233) (Fig 5A and 5B). The results are con-
trasted with another results that thapsigargin inhibits ionomycin-induced Ca2+ release but
does not affect Ca2+ influx (P = 0.003, t(9) = 4.029) (Fig 5C and 5D) and confirmed the
PCB19-induced SOCE inhibition. We also found that PCB19 successfully inhibited thapsigar-
gin-induced Ca2+ influx in the experiment with PCB19 challenge before the reintroduction of
2.2 mM extracellular Ca2+ (P< 0.0001, t(12) = 10.42) (Fig 5E and 5F).
NDL-PCBs inhibit ionomycin- or thapsigargin-induced [Ca2+]i increases
via SOCE
To test our hypothesis that PCB19 inhibits SOCE, we next devised a method of teasing apart
Ca2+ release from Ca2+ influx, both of which are potentially affected by PCB19 treatment, in
order to precisely define the effects of PCB19 on SOCE. Towards this end, we added PCB19
during the sustained Ca2+ phase evoked by thapsigargin, which itself depletes intracellular
Ca2+ pools, thereby eliminating any PCB19-induced Ca2+ release. Thapsigargin treatment led
to a prolonged high level of [Ca2+]i because of the interplay between Ca2+ release and SOCE.
In this condition, PCB19 decreased thapsigargin-induced sustained Ca2+ levels (Fig 6A).
NDL-PCBs Inhibit Store-Operated Ca2+ Entry
PLOS ONE | DOI:10.1371/journal.pone.0150921 March 10, 2016 5 / 19
Fig 3. PCB19 does not affect InsP3 production. A, PC12 cells were treated with 50 μMPCB4, PCB19, PCB50, or PCB100, or 300 nM bradykinin, for 15
seconds. Subsequently, InsP3 production was measured.B, Cells were preincubated either with (black bar) or without (blank bar) 50 μMPCB19 for 3 min
and then treated with 300 nM bradykinin for 15 seconds. Number of experiments are depicted in bar graph and each point represents mean ± SEM. BK,
bradykinin.
doi:10.1371/journal.pone.0150921.g003
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Fig 4. Ca2+ influxes stimulated by PCB19 are relatively small compared to those stimulated by intracellular Ca2+-mobilizing chemicals. A, Fura-
2-loaded PC12 cells were challenged with 50 μMPCB19 in the presence (left) or absence (right) of 2.2 mM extracellular free Ca2+. Ca2+ increases were also
monitored upon reintroduction of 2.2 mMCaCl2 in the condition lacking extracellular Ca
2+. B and C, Experiments were performed as in (A), but with the
addition of 1 μM thapsigargin (B) or 300 nM ionomycin (C). D, Peak height of [Ca2+]i increase was monitored and represented as mean ± SEM. E and F,
Cells were treated with 300 nM ionomycin in the absence of extracellular free Ca2+ with (gray trance) or without (black trace) the pretreatment of 50 μM
NDL-PCBs Inhibit Store-Operated Ca2+ Entry
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Of particular note was our observation that PCB19 showed an inhibitory effect at the time
point at which thapsigargin had already depleted Ca2+ pools and induced SOCE. Since these
experimental conditions were able to suitably dissect the effect of PCB19 on SOCE alone, we
proceeded to test the effects of other NDL-PCBs on SOCE. In addition to PCB19, PCB4,
PCB50, and PCB100 also inhibited thapsigargin-evoked SOCE in concentration-dependent
manners (Fig 6B). The potency order of NDL-PCBs with respect to SOCE inhibition was
PCB19 = PCB100 PCB50 PCB4; however, these differences were rather subtle. While
PCB19, PCB4, PCB50, and PCB100 showed complete inhibition of thapsigargin-evoked
SOCE, PCB36 showed marginal inhibition than other NDL-PCBs, and TCDD did not affect
SOCE at all (S1 Fig).
PCB19 inhibits store-operated currents and Ca2+ influx
Although we excluded the possibilities that PCB19 affects GPCR or PLC activities, the possibil-
ity still remains that PCB19 affects Ca2+ signaling machinery to replenish Ca2+ stores and/or to
recover [Ca2+]i levels to the basal level more efficiently (for example, by activating plasma
membrane Ca2+-ATPases (PMCA) [26] or Na+/Ca2+ exchangers (NCX) [27]). In this scenario,
PCB19 could inhibit SOCE indirectly, without having any direct effect on SOCE-mediated
Ca2+ influx. To test the possibility of an indirect SOCE inhibition via a fast recovery of [Ca2+]i
levels, we used bepridil (Na+ site specific NCX inhibitor), and caloxin (isoform-nonselective
PMCA inhibitor). Interestingly PCB19-mediated SOCE inhibition is not affected by the pres-
ence of bepridil or caloxin, implying that PCB19’s effect is not contributed by the activation of
PMCA or NCX (S2 Fig). Moreover, to address a direct effect on SOCE-mediated Ca2+ influx,
we monitored SOCE-induced Mn2+ quenching under the presence of PCB19. When fura-2 is
excited at 360 nm (its isosbestic wavelength), its fluorescence is not affected by cytosolic Ca2+,
whether originating from the intracellular pool or the extracellular space. Therefore, if Mn2+ is
added in the extracellular solution, any changes in fluorescence result from binding of fura-2 to
Mn2+, the latter of which is only able to enter cells from extracellular space. We found that
PCB19 decreased the rate of thapsigargin-induced fluorescence quenching, indicating that
thapsigargin-induced SOCE is specifically inhibited by PCB19 like as a SOCE inhibitor 1-{-[3-
(4-methoxyphenyl)propoxy]-4-methoxyphenyl}-1H- imidazole hydrochloride (SK&F96365)
[28] (vehicle vs SK&F96365: P< 0.0001, t(7) = 20.01; vehicle vs PCB19: P< 0.0001, t(10) =
9.427) (Fig 7A and 7B). We also confirmed the effect of PCB19 by measuring store-operated
currents directly by whole-cell patch clamping experiments. The infusion of BAPTA, an intra-
cellular Ca2+ chelator, via a patch pipette in the whole cell configuration triggers store-operated
currents. Also thapsigargin and InsP3 were included in pipette solution to deplete the intracel-
lular calcium stores. Interestingly, store-operated currents were completely eliminated by pre-
incubation with PCB19 (P = 0.0016, t(6) = 5.439) (Fig 7C and 7D), suggesting that PCB19
directly targets channels involved in store-operated currents rather than Ca2+ signaling
machinery.
PCB19 inhibits SOCE in a similar manner of known SOCE antagonists
Finally, we compared PCB19-mediated inhibition of SOCE to that of previously reported
SOCE-modulating chemicals including SK&F96365 and 2-aminoethyldiphenyl borate (2APB)
[29]. 2APB decreased thapsigargin-induced sustained elevations of Ca2+ levels in a manner
PCB19 for 100 sec. Ca2+ influx was then measured upon reintroduction of 2.2 mMCaCl2 (Ca
2+) into the extracellular space to monitor the ionomycin-induced
Ca2+ influx. Number of experiments are depicted in bar graph and each point represents mean ± SEM. TG, thapsigargin.
doi:10.1371/journal.pone.0150921.g004
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Fig 5. PCB19 inhibits ionomycin and thapsigargin-induced Ca2+ influxes. (A, C, E) Fura-2-loaded PC12 cells were incubated in Ca2+-free Locke’s
solution, challenged with 50 μMPCB19, 1 μM thapsigargin or 300 nM ionomycin, and treated with 2.2 mMCaCl2 at the indicated time (arrow). (B, D, F) The
[Ca2+]i level at point a (Ca2+ release) and b (Ca2+ influx) were quantitatively analyzed using calcium traces and expressed as % of controls. Number of
experiments are depicted in bar graph and each point represents mean ± SEM. TG, thapsigargin. **P < 0.01.
doi:10.1371/journal.pone.0150921.g005
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Fig 6. PCB19 blunts thapsigargin-induced increases in sustained [Ca2+]i levels. A, Fura-2-loaded PC12 cells were treated with 1 μM thapsigargin; 5
minutes later (at the sustained phase), cells were challenged with 50 μM of either PCB4, PCB19, or PCB100. Data presented include typical Ca2+ traces from
more than five independent experiments. B, Concentration-dependent effects of PCBs on thapsigargin-induced SOCE. Decreases in Ca2+ levels were
monitored upon stimulation with various concentrations of PCB4 (filled triangles), PCB19 (filled squares), PCB50 (blank circles), and PCB100 (blank
triangles). Net decreases in [Ca2+]i are expressed as % of controls (thapsigargin-induced Ca
2+ levels without PCB19 treatment). Each point shown was
obtained from triplicate experiments and represents the mean ± SEM. TG, thapsigargin.
doi:10.1371/journal.pone.0150921.g006
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similar to PCB19; furthermore, subsequent addition of PCB19 did not increase the amplitude
of this inhibition (Fig 8A), implying that PCB19 and 2APB act either on the same target or on
parallel targets in the common pathway. This conclusion was confirmed by the result that
2APB with different concentrations (10–100 μM) commonly show the overlapped effect of
2APB and PCB19 (S3 Fig). The same experiment generated similar results when performed in
the reverse order (e.g. PCB19 first, then 2APB; Fig 8B) and when performed with the other
SOCE inhibitor, SK&F96365 (Fig 8C and 8D). Together, these results suggest that PCB19,
SK&F96365, and 2APB share a common target by which they inhibit SOCE.
Fig 7. PCB19 inhibits store-operated cation entry. A, Mn2+-induced fura-2 fluorescence quenching was recorded in fura-2/AM-loaded PC12 cells. The
fluorescence intensities at 360 nm (F360) was monitored with 1 mMMnCl2 (arrow), after the preincubation of thapsigargin (TG) with PCB19 or SK&F96365
(SK&F) in the absence of extracellular free Ca2+. B, The changes in time (Δt) during the fluorescence changes (arbitrary units) were quantitatively analyzed
with the results in A. C, Ca2+ store depletion-induced cation influx was measured in PC12 cells with whole-cell patch clamp experiments. Currents were
activated following dialysis with 10 mM BAPTA and ramp pulses of membrane potentials from -100 to +100 mV were applied to monitor SOCE current.
Typical traces of Ca2+ store depletion-induced cation influxes with (gray trace) and without (black trace) 50 μMPCB19 are depicted.D, Comparison of
average peak store-operated current densities (pA/pF). Number of experiments are depicted in bar graph and each point represents mean ± SEM.
**P < 0.01.
doi:10.1371/journal.pone.0150921.g007
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Fig 8. PCB19 inhibits thapsigargin-induced SOCE in a manner similar to other SOCE antagonists. A, Fura-2-loaded PC12 cells were treated with 1 μM
thapsigargin (TG), then sequentially challenged with 100 μMPCB19 and 30 μM 2-aminoethylphenyl borate (2APB).B, Cells were treated with 1 μM
thapsigargin, challenged with 20 μM 2APB, and then treated with 50 μMPCB19.C, Cells were treated with 1 μM thapsigargin, then challenged sequentially
with 100 μMPCB19 and 20 μMSK&F96365 (SKF).D, Cells were treated with 1 μM thapsigargin, challenged with 20 μMSK&F96365, and then treated with
50 μMPCB19. The [Ca2+]i level at point a, b, and c were quantitatively analyzed using calcium traces. Number of experiments are depicted in bar graph and
each point represents mean ± SEM.
doi:10.1371/journal.pone.0150921.g008
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Discussion
GPCR-mediated Ca2+ signaling is known to be modulated by multiple mechanisms. Activation
of GPCRs and PLC produces InsP3, which binds to InsP3 receptors near intracellular Ca
2+
stores (e.g. endoplasmic reticulum (ER)) and induces Ca2+ release from these stores, thereby
depleting them of Ca2+. After Ca2+ is depleted from intracellular stores, they must be replen-
ished. This occurs via Ca2+ influx from the extracellular space in a process known as SOCE
[25,30]. Therefore, SOCE serves a very important role in enabling GPCR-mediated Ca2+ signal-
ing. In this study, we demonstrated for the first time that PCB19 inhibits SOCE, a process that
is normally activated downstream from PLC activation and depletion of thapsigargin-sensitive
Ca2+ stores. We present the following evidence in support of this idea: (1) PCB19 reduces bra-
dykinin-induced Ca2+ increases without inhibiting bradykinin-induced InsP3 production, (2)
PCB19 inhibits thapsigargin-induced Ca2+ influx as well as elevation of sustained Ca2+ levels,
(3) PCB19 reduces store-operated currents triggered by intracellular challenges with Ca2+ che-
lators, and (4) PCB19 does not affect Ca2+ levels in cells treated with SOCE inhibitors.
It has been reported that NDL-PCBs themselves are capable of triggering Ca2+ release [31].
Numerous studies in the last decade have elucidated that NDL-PCBs induce Ca2+ release and
its source is ryanodine receptor-Ca2+ channel complex type 1 (RyR1). Eversince Wong and
Pessah (1996) firstly reported the NDL-PCB-mediated Ca2+ release [17], the structure-activity
relationship of NDL-PCB on RyR1 activation has come to be found [19]. However, we found
for the first time the NDL-PCB-induced SOCE inhibition which has been obscured by
NDL-PCB-induced Ca2+. Thus, we conclude that PCB19 appears to have a dual effect on
SOCE: (1) PCB19 activates SOCE by promoting Ca2+ release, but (2) PCB19 inhibits SOCE by
blocking Ca2+ influx from the extracellular space.
Examining structure-activity relationships is a helpful approach for distinguishing target
mechanisms when the chemical bears multiple target sites. In our study, we compared the effects
of PCB4, PCB19, PCB50, and PCB100, and found that their inhibitory potencies against SOCE
ranked in the following order: PCB19 = PCB100 PCB50 PCB4. Even though PCB36 and
PCB19 are both trichlorinated biphenyls, they exhibited a large discrepancy in activities because
of the substituted chlorine atom in the ortho position in PCB19. In addition, a PCB with five
substituted chlorine atoms (i.e. PCB100) showed similar potency to those of PCBs with three or
four substituted chlorine atoms (i.e. PCB19, PCB50). Also, we did not observe any significant
differences in potencies between PCBs with (i.e. PCB50, PCB100) and without (i.e. PCB4,
PCB19) a substituted chlorine atom in the para position. From these results we conclude that
(1) only NDL-PCBs inhibit SOCE, whereas DL-PCBs are less effective on SOCE inhibition, and
(2) neither the number nor the position of the chlorine atom substitution in NDL-PCBs corre-
lates with the SOCE inhibition activity of the molecule. Comparing our data to previously
reported studies of PCBs raises some interesting issues. First, NDL-PCBs have been reported to
potentiate GABAA channel activity, but the potency of this potentiation has been shown to
decrease according to the number of the substituted chlorine atom, with para-substituted NDL
having almost negligible potency [32]. Second, structure-activity relationship of SOCE inhibi-
tion is different from the one reported for ryanodine receptors, another target for NDL-PCBs
[18–19], because para-substituted NDL was found to be active in SOCE inhibition with a strik-
ingly different potency profile. Although complete structure-activity relationships require more
data from additional PCBs to be fully constructed, we conclude that PCB-mediated inhibition of
SOCE occurs through a unique mechanism which has not yet been described (e.g. independent
of activation of either the ryanodine receptor or the GABAA receptor).
PCB19 has been suggested to perturb membrane structure and affect channel activity. PCBs
affect channels and ionotropic receptors, including the voltage-sensitive Ca2+ channel [23,24,33],
NDL-PCBs Inhibit Store-Operated Ca2+ Entry
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the GABAA receptor [32,34], and the hERG K
+ channel [35]. Others have suggested an alterna-
tive possibility that lipid-soluble PCB19 can diffuse into the cell and affect cytosolic molecules,
including machineries that control intracellular Ca2+ concentration. We think the activity profile
of PCB19 in two different cells provides insights into the action mechanism. Recent investiga-
tions have revealed that the molecular players of SOCE are ORAI1 and STIM1 [36]. After Ca2+
pool depletion is recognized by STIM1 (an EF-hand containing Ca2+ sensor in ER), STIM1
moves to ER-plasma membrane junctions and opens ORAI1 channel by ORAI1-STIM1 interac-
tion [36]. Variations in ORAI family (i.e. ORAI1α, ORAI1β, ORAI2, ORAI3) and STIM family
(STIM1, STIM1L, STIM2.1, STIM2.2, STIM2.3) allows different characteristics of SOCE in dif-
ferent cell types [37]. Especially STIM1-mediated SOCE is reported in PC12 cells [38]. Further
investigation such as subtype specific knock down approaches, visualization of SOCE compo-
nents and structural analysis of co-crystals of PCBs will provide a much clearer view of the action
mechanism of PCB.
In toxicological aspect, an important finding of this study was that NDL-PCBs affect GPCR
signaling by inhibiting SOCE. Communication between neurons and other cells, a process
heavily mediated by neurotransmitters, is known to be critical for neurons to fulfil their roles
in higher brain functions. Therefore, GPCRs, which serve as receptors for neurotransmitters,
are often effective targets for neurotoxicological agents. To date, PCB-induced GPCR modula-
tion has been studied only on the level of receptor expression. Long-term exposure to PCB
for the embryo and/or neonate causes decreases in muscarinic receptor expression [39,40].
Whereas these previous findings support the hypothesis that the neurodevelopmental toxicity
of PCB is related to long-term changes in GPCR expression patterns, our findings explain the
neurophysiological toxicity of PCB on a shorter time scale. Compounds that interfere with
GPCR signaling can affect the efficiency of medicines known to modulate GPCR activity or
alter the concentration of neurotransmitters needed to achieve a desired effect (for example,
serotonin-specific reuptake inhibitors or monoamine oxidase inhibitors, used for treating
major depression). Furthermore, they evoke neurobehavioral disturbances by causing changes
in synaptic plasticity, such as affecting long-term potentiation or long-term depression. A large
body of evidence has accumulated in support of the idea that the neurobehavioral toxicities of
PCBs are due to their effects on synaptic plasticity [41–43]. Notably, GPCR signaling pathways
are key modulators of synaptic plasticity and are crucial for evoking metabotropic glutamate
receptor-dependent long-term depression [44] and for inducing experience-dependent synap-
tic modifications [45]. Importantly, this study identifies SOCE as a novel toxicological target of
NDL-PCBs, thereby making an important contribution to our understanding of the mecha-
nism of neurobehavioral toxicity of NDL-PCBs.
Materials and Methods
Chemicals
PCB4, PCB19, PCB36, PCB50, and PCB100 were obtained from Chem Service (West Chester,
PA, USA). ATP, bradykinin, GTP, sodiummethane sulfonate, glucose, N-hydroxyethylethyle-
nediamine triacetic acid, 1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’- tetraacetic acid (BAPTA),
HEPES, and sulfinpyrazone were purchased from Sigma (St. Louis, MO, USA). SK&F96365 and
2-aminoethoxyphenyl borate (2-APB) were obtained from Tocris (Bristol, UK). Thapsigargin
was purchased from Alomone Labs (Jerusalem, Israel). Fura-2/acetoxymethylester (Fura-2/AM)
was obtained fromMolecular Probes (Eugene, OR, USA). [3H] Inositol 1,4,5-trisphosphate
(InsP3) was purchased from GE Healthcare Life Sciences (Amersham, Piscataway, NJ, USA).
Bovine calf serum and horse serum were obtained from HyClone (Logan, UT, USA). RPMI
1640 and penicillin/streptomycin were purchased from Gibco (Grand Island, NY, USA).
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Cell culture
PC12 rat pheochromocytoma cells [46] were grown in RPMI 1640 medium supplemented with
10% (v/v) heat-inactivated bovine calf serum, 5% (v/v) heat-inactivated horse serum, and 1%
(v/v) penicillin/streptomycin. The final concentrations of penicillin and streptomycin were 5
units/ml and 50 μg/ml, respectively. Culture medium was changed daily, and cells were subcul-
tured weekly.
Measurement of intracellular Ca2+ concentrations ([Ca2+]i)
The fluorescent Ca2+ indicator, fura-2, was used to determine [Ca2+]i according to previously
reported methods [47]. Briefly, cell suspensions were incubated in Locke's solution (154 mM
NaCl, 5.6 mM KCl, 5.6 mM glucose, 2 mM CaCl2, 1.2 mMMgCl2, and 5 mMHEPES buffer
adjusted to pH 7.4) supplemented with 3 μM fura-2/AM for 50 min at 37°C with continuous
stirring. Loaded cells were then washed twice with Locke's solution; sulfinpyrazone (250 μM)
was added to all solutions to prevent dye leakage. Fluorescence ratios were monitored using
dual excitation wavelengths of 340 and 380 nm and detecting the ratio of resultant intensities
at an emission wavelength of 500 nm. For the experiments in the extracellular Ca2+-free condi-
tion, cells were incubated with Ca2+-free Locke’s solution (156.2 mM NaCl, 5.6 mM KCl, 5.6
mM glucose, 1.2 mMMgCl2, 100 μM EGTA, 5 mMHEPES buffer adjusted to pH 7.4) for 30
sec (Fig 4) or 5 min (Fig 5), and then 2.2 mM CaCl2 was challenged to induce Ca
2+ influx. Con-
version of fluorescence ratios into [Ca2+]i was performed as described [48].
Measurement of InsP3 production
InsP3 mobilization was determined by competition assays using [
3H]InsP3 as described previ-
ously [49,50]. Briefly, to quantify InsP3 production, confluent cells in 6-well plates were stimu-
lated with the drugs of interest, followed by the addition of ice-cold 5% trichloroacetic acid
containing 10 mM EGTA to terminate the reactions and lyse the cells. Lysate supernatants
were saved, and trichloroacetic acid was extracted with diethylether. Aqueous fractions remain-
ing after the final extraction were neutralized with 200 mM Trizma base adjusted to pH 7.4.
20 μl of the extract were added to 20 μl of assay buffer (0.1 M Tris buffer containing 4 mM
EDTA) and 20 μl of [3H]InsP3 (100 nCi/ml). The resultant mixture was incubated for 15 min
on ice and then centrifuged at 2,000 x g for 10 min. 100 μl of water and 1 ml of liquid scintilla-
tion cocktail were added to the pellet to measure its radioactivity. The InsP3 concentrations of
the samples were determined by comparison to a standard curve and expressed as pmol/mg of
protein. Total cellular protein concentrations were determined with the Bradford method after
sonication of cells.
Measurement of Ca2+ influx from extracellular space
The Mn2+ quenching assay was performed as previously described [51–52] to measure Ca2+
influx from the extracellular space. Briefly, fura-2-loaded cells were pretreated with thapsigar-
gin, SK&F96364 and/or PCB19 in extracellular Ca2+-free condition. The slope of the Mn2+-
induced changes in fluorescence intensities were monitored (wavelengths: 360 nm excitation
and 510 nm emission) upon 1 mMMnCl2 treatment.
Electrophysiology
Patch-clamp experiments were conducted in the whole-cell configuration using fire-polished
pipettes with a final resistance of 3–5 MO. To establish the whole-cell configuration, cell-
attached patches were generated, and the cell membrane underneath the patch pipette was
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ruptured by gentle suction. Store-operated currents were recorded as described previously [53]
with the bath solution which had the following composition: 135 mM sodium methanesulfo-
nate, 5 mM NaCl, 10 mMHEPES, and 10 mMN-hydroxyethylethylenediamine triacetic acid;
pH was adjusted to 7.2 with HCl. The pipette solution had the following composition: 135 mM
Cesium methanesulfonate, 10 mM BAPTA, 10 mMHepes, 5 mMMgCl2 (pH 7.2 with CsOH).
Thapsigargin (1 μM) and InsP3 (1 μM) were also included in pipette solution to deplete the
intracellular calcium stores. To monitor SOCE current, cells at a holding potential of -70 mV
were applied by ramp pulses of membrane potentials from -100 to +100 mV. Transient and
leak currents were not canceled. Currents were sampled at 5 kHz and digitally filtered at 1 kHz
using either an Axopatch 200B with a Digidata 1200 interface or a Multiclamp 700B amplifier
with a Digidata 1440 interface. Data acquisition and analysis were performed using the pClamp
program (Molecular Devices, Union City, CA, USA). All experiments were performed at room
temperature (20–23°C).
Data analysis
All quantitative data are expressed as means ± SEM. The Origin for Windows program (Micro-
cal Software Inc., Northhampton, MA, USA) was used to calculate IC50 values. Differences were
determined by one-way ANOVA and considered to be significant only for P values< 0.05.
Supporting Information
S1 Fig. TCDD and PCB36 do not affect thapsigargin-induced increases of [Ca2+]i. A-B,
Fura-2-loaded PC12 cells were challenged with 50 nM TCDD (A), or 50 μM PCB36 (B) and
subsequently treated with 1 μM thapsigargin (TG). C-D, Fura-2-loaded PC12 cells were treated
with 1 μM thapsigargin (TG), then sequentially challenged with 50 nM TCDD (C), or 50 μM
PCB36 (D). Responses to thapsigargin alone, without chemical pretreatment, are also depicted
(dotted traces).
(TIF)
S2 Fig. PMCA inhibitors fail to block the PCB19-mediated SOCE inhibition. A, Fura-
2-loaded PC12 cells were treated with 1 μM thapsigargin (TG) in the absence (black trace) or
the presence of 10 μM bepridil (dark gray trace) or 10 μM caloxin (light gray trace), and then
treated with 50 μM PCB19. B, Net decreases in [Ca2+]i are expressed as % of controls (thapsi-
gargin-induced Ca2+ levels without PCB19 treatment). Number of experiments are depicted in
bar graph and each point represents mean ± SEM.
(TIF)
S3 Fig. PCB19 inhibits thapsigargin-induced SOCE in manner similar to 2APB. A, Fura-
2-loaded PC12 cells were treated with 1 μM thapsigargin (TG), then sequentially challenged
with indicated concentration of 2APB (10 μM, black trace; 20 μM, dark gray trace; 100 μM,
light gray trace), and then treated with 50 μM PCB19. B, The [Ca2+]i level at point a, b, and c
were quantitatively analyzed using calcium traces. Number of experiments are depicted in bar
graph and each point represents mean ± SEM.
(TIF)
Acknowledgments
We are grateful to Dr. Eun-Mi Hur, Dr. Hyung Sik Kim, and Mr. Han-Hee Lee for reading
the manuscript. This work was supported by the National Research Foundation of Korea
NDL-PCBs Inhibit Store-Operated Ca2+ Entry
PLOS ONE | DOI:10.1371/journal.pone.0150921 March 10, 2016 16 / 19
(2015048003, 2013R1A2A2A01014688, 2013M3C7A1044016). The authors declare no com-
peting financial interests.
Author Contributions
Conceived and designed the experiments: SYC KTK. Performed the experiments: SYC KL SHL
YP. Analyzed the data: SYC SHJ SC. Wrote the paper: SYC KTK.
References
1. Breivik K, Sweetman A, Pacyna JM, Jones KC (2002) Towards a global historical emission inventory
for selected PCB congeners—a mass balance approach. 1. Global production and consumption. Sci
Total Environ. 290:181–98. PMID: 12083709
2. Grossman E (2013) Nonlegacy PCBs: pigment manufacturing by-products get a second look. Environ.
Health Perspect. 121:A86–A93. doi: 10.1289/ehp.121-a86 PMID: 23454657
3. Clarkson TW (1995) Environmental contaminants in the food chain. Am J Clin Nutr. 61:S682–6.
4. Faroon O, Jones D, de Rosa C (2001) Effects of polychlorinated biphenyls on the nervous system. Tox-
icol Ind Health. 16:305–33.
5. Naveau E, Pinson A, Gérard A, Nguyen L, Charlier C, Thomé JP, et al. (2014) Alteration of rat fetal
cerebral cortex development after prenatal exposure to polychlorinated biphenyls. PLoS One. 9:
e91903. doi: 10.1371/journal.pone.0091903 PMID: 24642964
6. Grandjean P, Landrigan PJ (2014) Neurobehavioural effects of developmental toxicity. Lancet Neurol.
13:330–8. doi: 10.1016/S1474-4422(13)70278-3 PMID: 24556010
7. Dewailly E, Ayotte P, Laliberté C, Weber JP, Gingras S, Nantel AJ (1996) Polychlorinated biphenyl
(PCB) and dichlorodiphenyl dichloroethylene (DDE) concentrations in the breast milk of women in Que-
bec. Am J Public Health. 86:1241–6. PMID: 8806375
8. Fangstrom B, Strid A, Grandjean P, Weihe P, Bergman A (2005) A retrospective study of PBDEs and
PCBs in humanmilk from the Faroe Islands. Environ Health. 14:4–12.
9. Winneke G, Bucholski A, Heinzow B, Krämer U, Schmidt E, Walkowiak J, et al. (1998) Developmental
neurotoxicity of polychlorinated biphenyls (PCBS): cognitive and psychomotor functions in 7-month old
children. Toxicol Lett. 102–103:423–8. PMID: 10022290
10. Winneke G, Walkowiak J, Lilienthal H (2002) PCB-induced neurodevelopmental toxicity in human
infants and its potential mediation by endocrine dysfunction. Toxicology. 181–182:161–5. PMID:
12505303
11. Eriksson P, Fischer C, Fredriksson A (2006) Polybrominated diphenyl ethers, a group of brominated
flame retardants, can interact with polychlorinated biphenyls in enhancing developmental neurobeha-
vioral defects. Toxicol Sci. 94:302–9. PMID: 16980691
12. Boix J, Cauli O, Leslie H, Felipo V (2011) Differential long-term effects of developmental exposure to
polychlorinated biphenyls 52, 138 or 180 on motor activity and neurotransmission. Gender dependence
and mechanisms involved. Neurochem Intl. 58:69–77.
13. Van den Berg M, Birnbaum LS, Denison M, De Vito M, FarlandW, Feeley M, et al. (2006) The 2005
World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins
and dioxin-like compounds. Toxicol Sci. 93:223–41. PMID: 16829543
14. Shafer TJ, MundyWR, Tilson HA, Kodavanti PR (1996) Disruption of inositol phosphate accumulation
in cerebellar granule cells by polychlorinated biphenyls: a consequence of altered Ca2+ homeostasis.
Toxicol Appl Pharmacol. 141:448–55. PMID: 8975770
15. Wong PW, BrackneyWR, Pessah IN (1997) Ortho-substituted polychlorinated biphenyls alter micro-
somal calcium transport by direct interaction with ryanodine receptors of mammalian brain. J Biol
Chem. 272:15145–53. PMID: 9182535
16. Bae J, Peters-Golden M, Loch-Caruso R (1999) Stimulation of pregnant rat uterine contraction by the
polychlorinated biphenyl (PCB) mixture aroclor 1242 may be mediated by arachidonic acid release
through activation of phospholipase A2 enzymes. J Pharmacol Exp Ther. 289(2):1112–20. PMID:
10215694
17. Wong PW, Pessah IN (1996) Ortho-substituted polychlorinated biphenyls alter calcium regulation by a
ryanodine receptor-mediated mechanism: structural specificity toward skeletal- and cardiac-type micro-
somal calcium release channels. Mol Pharmacol. 49(4):740–51. PMID: 8609904
18. Pessah IN, Cherednichenko G, Lein PJ (2010) Minding the calcium store: Ryanodine receptor activa-
tion as a convergent mechanism of PCB toxicity. Pharmacol Ther. 125:260–85. doi: 10.1016/j.
pharmthera.2009.10.009 PMID: 19931307
NDL-PCBs Inhibit Store-Operated Ca2+ Entry
PLOS ONE | DOI:10.1371/journal.pone.0150921 March 10, 2016 17 / 19
19. Pessah IN, Hansen LG, Albertson TE, Garner CE, Ta TA, Do Z, et al. (2006) Structure-activity relation-
ship for noncoplanar polychlorinated biphenyl congeners toward the ryanodine receptor-Ca2+ channel
complex type 1 (RyR1). Chem Res Toxicol. 19:92–101. PMID: 16411661
20. Kodavanti PR, Osorio C, Royland JE, Ramabhadran R, Alzate O (2011) Aroclor 1254, a developmental
neurotoxicant, alters energy metabolism- and intracellular signaling-associated protein networks in rat
cerebellum and hippocampus. Toxicol Appl Pharmacol. 256:290–9. doi: 10.1016/j.taap.2011.07.005
PMID: 21791222
21. Cocco S, Secondo A, Del Viscovo A, Procaccini C, Formisano L, Franco C, et al. (2015) Polychlori-
nated biphenyls induce mitochondrial dysfunction in SH-SY5Y neuroblastoma cells. PLoS One. 10:
e0129481. doi: 10.1371/journal.pone.0129481 PMID: 26101884
22. Wong PW, Garcia EF, Pessah IN (2001) Ortho-substituted PCB95 alters intracellular calcium signaling
and causes cellular acidification in PC12 cells by an immunophilin-dependent mechanism. J Neuro-
chem. 76:450–63. PMID: 11208908
23. Neal AP, Yuan Y, Atchison WD (2010) Allethrin differentially modulates voltage-gated calcium channel
subtypes in rat PC12 cells. Toxicol Sci. 116:604–13. doi: 10.1093/toxsci/kfq139 PMID: 20466778
24. LangeveldWT, Meijer M, Westerink RH (2012) Differential effects of 20 non-dioxin-like PCBs on basal
and depolarization-evoked intracellular calcium levels in PC12 cells. Toxicol Sci. 126:487–96. doi: 10.
1093/toxsci/kfr346 PMID: 22218490
25. Putney JW (2011) The physiological function of store-operated calcium entry. Neurochem Res.
36:1157–65. doi: 10.1007/s11064-010-0383-0 PMID: 21234676
26. Boczek T, Lisek M, Ferenc B, Kowalski A, Stepinski D, Wiktorska M, et al. (2014) Plasmamembrane
Ca2+-ATPase isoforms composition regulates cellular pH homeostasis in differentiating PC12 cells in a
manner dependent on cytosolic Ca2+ elevations. PLoS One. 9(7):e102352. doi: 10.1371/journal.pone.
0102352 PMID: 25014339
27. Sirabella R, Secondo A, Pannaccione A, Molinaro P, Formisano L, Guida N, et al. (2012) ERK1/2, p38,
and JNK regulate the expression and the activity of the three isoforms of the Na+ /Ca2+ exchanger,
NCX1, NCX2, and NCX3, in neuronal PC12 cells. J Neurochem. 122(5):911–22. doi: 10.1111/j.1471-
4159.2012.07838.x PMID: 22708976
28. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, et al. (1990) SK&F
96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J. 271:515–22. PMID: 2173565
29. Goto J, Suzuki AZ, Ozaki S, Matsumoto N, Nakamura T, Ebisui E, et al. (2010) Two novel 2-aminoethyl
diphenylborinate (2-APB) analogues differentially activate and inhibit store-operated Ca2+ entry via
STIM proteins. Cell Calcium. 47:1–10. doi: 10.1016/j.ceca.2009.10.004 PMID: 19945161
30. Cahalan MD (2009) STIMulating store-operated Ca2+ entry. Nat Cell Biol. 11:669–77. doi: 10.1038/
ncb0609-669 PMID: 19488056
31. Inglefield JR, MundyWR, Shafer TJ (2001) Inositol 1,4,5-triphosphate receptor-sensitive Ca2+ release,
store-operated Ca2+ entry, and cAMP responsive element binding protein phosphorylation in develop-
ing cortical cells following exposure to polychlorinated biphenyls. J Pharmacol Exp Ther. 297:762–73.
PMID: 11303068
32. Antunes Fernandes EC, Hendriks HS, van Kleef RG, Reniers A, Andersson PL, van den Berg M, et al.
(2010) Activation and potentiation of human GABAA receptors by non-dioxin-like PCBs depends on
chlorination pattern. Toxicol Sci. 118:183–90. doi: 10.1093/toxsci/kfq257 PMID: 20819908
33. Jo SH, Choi SY, Kim KT, Lee CO (2001) Effects of polychlorinated biphenyl 19 (2,2',6-trichlorobiphenyl)
on contraction, Ca2+ transient, and Ca2+ current of cardiac myocytes. J Cardiovasc Pharmacol. 38:11–
20. PMID: 11444494
34. Hendriks HS, Antunes Fernandes EC, Bergman A, van den Berg M, Westerink RH (2010) PCB-47,
PBDE-47, and 6-OH-PBDE-47 differentially modulate human GABAA and alpha4beta2 nicotinic acetyl-
choline receptors. Toxicol Sci. 118:635–42. doi: 10.1093/toxsci/kfq284 PMID: 20861069
35. Park MH, Park WS, Jo SH (2012) Acute alteration of cardiac ECG, action potential, I(Kr) and the human
ether-a-go-go-related gene (hERG) K+ channel by PCB 126 and PCB 77. Toxicol Appl Pharmacol.
262:60–9. doi: 10.1016/j.taap.2012.04.019 PMID: 22676973
36. Hogan PG (2015) The STIM1-ORAI1 microdomain. Cell Calcium 58(4):357–67. doi: 10.1016/j.ceca.
2015.07.001 PMID: 26215475
37. Rosado JA, Diez R, Smani T, Jardín I (2016) STIM and Orai1 Variants in Store-Operated Calcium
Entry. Front Pharmacol. 6:325. doi: 10.3389/fphar.2015.00325 PMID: 26793113
38. Thompson MA, Pabelick CM, Prakash YS (2009) Role of STIM1 in regulation of store-operated Ca2+
influx in pheochromocytoma cells. Cell Mol Neurobiol. 29(2):193–202. doi: 10.1007/s10571-008-9311-
0 PMID: 18807171
NDL-PCBs Inhibit Store-Operated Ca2+ Entry
PLOS ONE | DOI:10.1371/journal.pone.0150921 March 10, 2016 18 / 19
39. Coccini T, Randine G, Castoldi AF, Grandjean P, Ostendorp G, Heinzow B, et al. (2006) Effects of
developmental co-exposure to methylmercury and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) on cho-
linergic muscarinic receptors in rat brain. Neurotoxicology. 27:468–77. PMID: 16455139
40. Eriksson P, Lundkvist U, Fredriksson A (1991) Neonatal exposure to 3,3',4,4'-tetrachlorobiphenyl:
changes in spontaneous behaviour and cholinergic muscarinic receptors in the adult mouse. Toxicol-
ogy. 69:27–34. PMID: 1926153
41. Hussain RJ, Gyori J, DeCaprio AP, Carpenter DO (2000) In vivo and in vitro exposure to PCB 153
reduces long-term potentiation. Environ Health Perspect. 108:827–31. PMID: 11017886
42. Gilbert ME, MundyWR, Crofton KM (2000) Spatial learning and long-term potentiation in the dentate
gyrus of the hippocampus in animals developmentally exposed to Aroclor 1254. Toxicol Sci. 57:102–
11. PMID: 10966516
43. Altmann L, MundyWR,Ward TR, Fastabend A, Lilienthal H (2001) Developmental exposure of rats to a
reconstituted PCBmixture or aroclor 1254: effects on long-term potentiation and [3H]MK-801 binding in
occipital cortex and hippocampus. Toxicol Sci. 61:321–30. PMID: 11353141
44. Yang J, Seo J, Nair R, Han S, Jang S, Kim K, et al. (2011) DGKι regulates presynaptic release during
mGluR-dependent LTD. EMBO J. 30:165–80. doi: 10.1038/emboj.2010.286 PMID: 21119615
45. Choi SY, Chang J, Jiang B, Seol GH, Min SS, Han JS, et al. (2005) Multiple receptors coupled to phos-
pholipase C gate long-term depression in visual cortex. J Neurosci. 25:11433–43. PMID: 16339037
46. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromo-
cytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A. 73:2424–8. PMID:
1065897
47. Choi SY, Kim KT (1999) Capsaicin inhibits phospholipase C-mediated Ca2+ increase by blocking of
thapsigargin sensitive store-operated Ca2+ entry in PC12 cells. J Pharmacol Exp Ther. 291: 107–14.
PMID: 10490893
48. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved
fluorescence properties. J Biol Chem. 260:3440–50. PMID: 3838314
49. Choi SY, Kim YH, Lee YK, Kim KT (2001) Chlorpromazine inhibits store-operated calcium entry and
subsequent noradrenaline secretion in PC12 cells. Br J Pharmacol. 132:411–8. PMID: 11159689
50. Lee H, Suh BC, Kim KT (1997) Feedback regulation of ATP-induced Ca2+ signaling in HL-60 cells is
mediated by protein kinase A- and C-mediated changes in capacitative Ca2+ entry. J Biol Chem.
272:21831–8. PMID: 9268314
51. Song SK, Choi SY, Kim KT (1998) Opposing effects of protein kinase A and C on capacitative calcium
entry into HL-60 promyelocytes. Biochem Pharmacol. 56:561–7. PMID: 9783724
52. Choi SY, Kim YH, Lee YK, Kim KT (2001) Chlorpromazine inhibits store-operated calcium entry and
subsequent noradrenaline secretion in PC12 cells. Br J Pharmacol. 132:411–8. PMID: 11159689
53. Yoo AS, Cheng I, Chung S, Grenfell TZ, Lee H, Pack-Chung E, et al. (2000) Presenilin-mediated modu-
lation of capacitative calcium entry. Neuron. 27:561–72. PMID: 11055438
NDL-PCBs Inhibit Store-Operated Ca2+ Entry
PLOS ONE | DOI:10.1371/journal.pone.0150921 March 10, 2016 19 / 19
